FIM
CYTK icon

Freedom Investment Management’s Cytokinetics CYTK Stock Holding History

Freedom Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,963
Closed -$208K – 798
2024
Q1 		$208K Buy
+2,963
New +$229K 0.02% 740
2023
Q1 		– Sell
-6,057
Closed -$278K – 713
2022
Q4 		$278K Sell
6,057
-350
-5% -$15.1K 0.03% 595
2022
Q3 		$310K Sell
6,407
-249
-4% -$12K 0.04% 560
2022
Q2 		$262K Buy
+6,656
New +$268K 0.03% 615
2018
Q2 		– Sell
-138,296
Closed -$996K – 987
2018
Q1 		$996K Buy
138,296
+2,526
+2% +$21.7K 0.05% 371
2017
Q4 		$1.11M Buy
135,770
+3,949
+3% +$44.8K 0.06% 331
2017
Q3 		$1.91M Sell
131,821
-6,315
-5% -$86.3K 0.1% 148
2017
Q2 		$1.67M Buy
138,136
+830
+0.6% +$11.5K 0.1% 164
2017
Q1 		$1.76M Sell
137,306
-18,396
-12% -$215K 0.1% 142
2016
Q4 		$1.89M Sell
155,702
-38,653
-20% -$410K 0.12% 107
2016
Q3 		$1.78M Sell
194,355
-5,423
-3% -$56.6K 0.11% 115
2016
Q2 		$1.9M Buy
199,778
+9,514
+5% +$78.1K 0.13% 89
2016
Q1 		$1.34M Buy
190,264
+63,809
+50% +$466K 0.1% 150
2015
Q4 		$1.32M Buy
126,455
+110,508
+693% +$1.08M 0.1% 159
2015
Q3 		$1.54M Sell
15,947
-66,532
-81% -$454K 0.16% 94
2015
Q2 		$554K Buy
82,479
+23,854
+41% +$156K 0.06% 309
2015
Q1 		$397K Buy
58,625
+28,983
+98% +$216K 0.04% 386
2014
Q4 		$237K Buy
+29,642
New +$127K 0.03% 503

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Freedom Investment Management's CYTK Position: Q2 2024 in Review

Freedom Investment Management sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 2,963 shares — an estimated $208K sold.

Freedom Investment Management first reported a position in CYTK in Q4 2014 and held it in 18 quarters. The position peaked at $1.91M in Q3 2017. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • Freedom Investment Management reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • Freedom Investment Management sold 2,963 Cytokinetics shares in Q2 2024, an estimated $208K.
  • Freedom Investment Management first reported a position in Cytokinetics in Q4 2014 and held it in 18 quarters.
  • Freedom Investment Management's Cytokinetics position peaked at $1.91M in Q3 2017.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on Freedom Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.